Memantine (Paperback)


High Quality Content by WIKIPEDIA articles Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors. It was first synthesized by Eli Lilly and Company in 1968. Memantine is marketed under the brands Axura and Akatinol by Merz, Namenda by Forest, Ebixa and Abixa by Lundbeck and Memox by Unipharm. Despite years of research, there is little evidence of effect in mild to moderate Alzheimer's disease.

R379

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles3790
Delivery AdviceOut of stock

Toggle WishListAdd to wish list
Review this Item

Product Description

High Quality Content by WIKIPEDIA articles Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors. It was first synthesized by Eli Lilly and Company in 1968. Memantine is marketed under the brands Axura and Akatinol by Merz, Namenda by Forest, Ebixa and Abixa by Lundbeck and Memox by Unipharm. Despite years of research, there is little evidence of effect in mild to moderate Alzheimer's disease.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Book on Demand

Country of origin

Russian Federation

Release date

2013

Availability

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

First published

2013

Editors

,

Dimensions

279 x 210 x 4mm (L x W x T)

Format

Paperback - Trade

Pages

70

ISBN-13

978-5-512-24335-0

Barcode

9785512243350

Categories

LSN

5-512-24335-7



Trending On Loot